Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

A Pathway and Approach to Biomarker Validation and Qualification for Osteoarthritis Clinical Trials

Author(s): David J. Hunter, Elena Losina, Ali Guermazi, Deb Burstein, Marissa N. Lassere and Virginia Kraus

Volume 11 , Issue 5 , 2010

Page: [536 - 545] Pages: 10

DOI: 10.2174/138945010791011947

Price: $65

Abstract

This narrative review outlines the work done in other fields with regards biomarker validation and qualification and the lessons that we may learn from this experience. Defining a universally agreed upon path for biomarker validation and qualification is urgently needed to circumvent many of the hurdles faced in OA therapeutic development irrespective of whether we are discussing biochemical markers, imaging markers or other measures. This review proposes a path that may be suitable for osteoarthritis and poses some logical next steps that will take us in this direction.

Keywords: Osteoarthritis, biomarkers, imaging, biochemical marker, validation, qualification, intervention, surrogate


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy